Implantable cardioverter-defibrillator shock prevention does not reduce mortality: A systemic review

Heart Rhythm

Volumn 9, Issue 12, 2012, Pages 2068-2074

  Ha, Andrew H ^a   Ham, Inje ^a   Nair, Girish M ^b   Connolly, Stuart J ^b   Dorian, Paul ^c   Morillo, Carlos A ^b   Healey, Jeff S ^b  

^a MCMASTER UNIVERSITY   (Canada)

^b HAMILTON HEALTH SCIENCES   (Canada)

^c ST MICHAEL'S HOSPITAL   (Canada)

Author keywords

Implantable cardioverter defibrillator; Mortality; Prevention; Shock

Indexed keywords

AMIODARONE; ANTIARRHYTHMIC AGENT; AZIMILIDE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CELIVARONE; DOFETILIDE; METOPROLOL; PLACEBO; SOTALOL;

CARDIOVASCULAR MORTALITY; CATHETER ABLATION; CLINICAL EFFECTIVENESS; HEART EJECTION FRACTION; HEART VENTRICLE TACHYCARDIA; HUMAN; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; ISCHEMIC CARDIOMYOPATHY; META ANALYSIS; PRIMARY PREVENTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SYSTEMATIC REVIEW;

EID: 84870404695     PISSN: 15475271     EISSN: 15563871     Source Type: Journal    
DOI: 10.1016/j.hrthm.2012.08.032     Document Type: Article

References (49)

1. SJ Connolly, M Gent, RS Roberts et al. Canadian implantable defibrillator study (CIDS): a randomized trial of the implantable cardioverter defibrillator against amiodarone Circulation 101 2000 1297 1302
2. The Antiarrhythmics versus Implantable Defibrillator (AVID) Investigators: a comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias. N Engl J Med 1997;337:1576-1583.
3. AJ Moss, W Zareba, WJ Hall et al. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction N Engl J Med 346 2002 877 883
4. GH Bardy, KL Lee, DB Mark et al. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure N Engl J Med 352 2005 225 237
5. AJ Moss, H Greenberg, RB Case et al. Long-term clinical course of patients after termination of ventricular tachyarrhythmia by an implanted defibrillator Circulation 110 2004 3760 3765
6. JE Poole, GW Johnson, AS Hellkamp et al. Prognostic importance of defibrillator shocks in patients with heart failure N Engl J Med 359 2008 1009 1017
7. M Runsio, A Kallner, G Kallner, M Rosenqvist, L. Bergfeldt Myocardial injury after electrical therapy for cardiac arrhythmias assessed by troponin-T release Am J Cardiol 79 1997 1241 1245
8. SL Pinski, GJ. Fahy The proarrhythmic potential of implantable cardioverter defibrillators Circulation 92 1995 1651 1664
9. SJ Connolly, P Dorian, RS Roberts et al. Comparison of beta-blockers, amiodarone plus beta-blockers, or sotalol for prevention of shocks from implantable cardioverter defibrillators: the OPTIC Study: a randomized trial. JAMA 295 2006 165 171
10. A Pacifico, SH Hohnloser, JH Williams et al. Prevention of implantable-defibrillator shocks by treatment with sotalol N Engl J Med 340 1999 1855 1862
11. V Kuhlkamp, C Mewis, J Mermi, RF Bosch, L. Seipel Suppression of sustained ventricular tachyarrhythmias: a comparison of d,l-sotalol with no antiarrhythmic drug treatment J Am Coll Cardiol 33 1999 46 52
12. K Kettering, C Mewis, V Dornberger, R Vonthein, RF Bosch, V. Kuhlkamp Efficacy of metoprolol and sotalol in the prevention of recurrences of sustained ventricular tachyarrhythmias in patients with an implantable cardioverter defibrillator Pacing Clin Electrophysiol 25 2002 1571 1576
13. P Dorian, M Borggrefe, HR Al-Khalidi et al. Placebo-controlled, randomized clinical trial of azimilde for prevention of ventricular tachyarrhythmias in patients with an implantable cardioverter defibrillator Circulation 110 2004 3646 3654
14. DS Echt, PR Liebson, LB Mitchell et al. Mortality and morbidity in patients receiving encainide, flecainide, or placebo The Cardiac Arrhythmia Suppression Trial. N Engl J Med 324 1991 781 788
15. AL Waldo, AJ Camm, H deRuyter et al. Effect of d-sotalol on mortality in patients with left ventricular dysfunction after recent and remote myocardial infarction. The SWORD Investigators Survival With Oral d-Sotalol. Lancet 348 1996 7 12
16. JA Cairns, SJ Connolly, R Roberts, M. Gent Randomised trial of outcome after myocardial infarction in patients with frequent or repetitive ventricular premature depolarisations: CAMIAT. Canadian Amiodarone Myocardial Infarction Arrhythmia Trial Investigators Lancet 349 1997 675 682
17. DG Julian, AJ Camm, G Frangin et al. Randomised trial of effect of amiodarone on mortality in patients with left-ventricular dysfunction after recent myocardial infarction: EMIAT. European Myocardial Infarct Amiodarone Trial Investigators Lancet 349 1997 667 674
18. VY Reddy, MR Reynolds, P Neuzil et al. Prophylactic catheter ablation for the prevention of defibrillator therapy N Engl J Med 357 2007 2657 2665
19. H Tanner, G Hindricks, M Volkmer et al. Catheter ablation of recurrent scar-related ventricular tachycardia using electroanatomical mapping and irrigated ablation technology: results of the prospective multicenter Euro-VT-Study J Cardiovasc Electrophysiol 21 2010 47 53
20. H Calkins, A Epstein, D Packer et al. Catheter ablation of ventricular tachycardia in patients with structural heart disease using cooled radiofrequency energy J Am Coll Cardiol 35 2000 1905 1914
21. MS Wathen, PJ DeGroot, MO Sweeney et al. PainFREE Rx II Investigators. Prospective randomized multicenter trial of empirical antitachycardia pacing versus shocks for spontaneous rapid ventricular tachycardia in patients with implantable cardioverter-defibrillators: Pacing Fast Ventricular Tachycardia Reduces Shock Therapies (PainFREE Rx II) trial results Circulation 110 2004 2591 2596
22. MM Gulizia, L Piraino, M Scherillo et al. A randomized study to compare ramp versus burst antitachycardia pacing therapies to treat fast ventricular tachyarrhythmias in patients with implantable cardioverter defibrillators Circ Arrhythmia Electrophysiol 2 2009 146 153
23. BL Wilkoff, BD Williamson, RS Stern et al. Strategic programming of detection and therapy parameters in implantable cardioverter-defibrillators reduces shocks in primary prevention patients J Am Coll Cardiol 52 2008 541 550
24. P Dorian, F Philippon, B Thibault et al. Randomized controlled study of detection enhancements versus rate-only detection to prevent inappropriate therapy in a dual-chamber implantable cardioverter-defibrillator Heart Rhythm 1 2004 540 547
25. AR Jadad, RA Moore, D Carroll et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials 17 1996 1 12
26. PR Kowey, HJ Crijns, EM Aliot et al. Efficacy and safety of celivarone, with amiodarone as calibrator, in patients with an implantable cardioverter-defibrillator for prevention of implantable cardioverter- defibrillator interventions or death. The ALPHEE Study Circulation 124 2011 2649 2660
27. K Seidl, B Hauer, NG Schwick, R Zahn, J. Senges Comparison of metoprolol and sotalol in preventing ventricular tachyarrhythmias after the implantation of cardioverter/defibrillator Am J Cardiol 82 1998 744 748
28. I Singer, H Al-Khalidi, I Niazi et al. Azimilide decreases recurrent ventricular tachyarrhythmias in patients with implantable cardioverter defibrillators J Am Coll Cardiol 43 2004 39 43
29. M O'Toole, G O'Neill, J Kluger, SL Bonney, CB. Billing Efficacy and safety of oral dofetilide in patients with an implanted defibrillator: a multicenter study. Circulation 100 1999 I-794
30. KH Kuck, A Schaumann, L Eckardt et al. Catheter ablation of stable ventricular tachycardia before defibrillator implantation in patients with coronary heart disease (VTACH): a multicentre randomised controlled trial Lancet 375 2010 31 40
31. M Koa-Wing, P Kojodjojo, PB Lim et al. Limited target ablation for ventricular tachycardia to prevent defibrillator therapy Heart Rhythm 6 2009 S354
32. M Gasparini, F Anselme, J Clementy et al. Biventricular versus right ventricular antitachycardia to terminate ventricular tachyarrhythmias in patients receiving cardiac resynchronization therapy: the ADVANCE CRT-D trial Am Heart J 159 2010 1116 1123
33. M Santini, M Lunati, P Defaye et al. Prospective multicenter randomized trial of fast ventricular tachycardia termination by prolonged versus conventional anti-tachycardia burst pacing in implantable cardioverter- defibrillator patients J Interv Card Electrophysiol 27 2010 127 135
34. JS Healey, SJ. Connolly Life and death after ICD implantation N Eng J Med 359 2008 1058 1059
35. P Dorian, SH Hohnloser, KE Thorpe et al. Mechanisms underlying the lack of effect of implantable cardioverter-defibrillator therapy on mortality in high-risk patients with recent myocardial infarction. Insights from the defibrillation in acute myocardial infarction trial (DINAMIT). Circulation 122 2010 2645 2652
36. Boston Scientific Corporation. Multicenter automatic defibrillator implantation trial-reduce inappropriate therapy (MADIT-RIT). National Library of Medicine (US), 2000. Cited Mar 17, 2012. Available at: http://clinicaltrials. gov/ct2/show/NCT00947310. NLM Identifier: NCT00947310.
37. SH Hohnloser, P Dorian, R Roberts et al. Effect of amiodarone and sotalol on ventricular defibrillation threshold: the optimal pharmacologic therapy in cardioverter defibrillator patients (OPTIC) trial. Circulation 114 2006 104 109
38. W Jung, M Manz, L Pizzulli, D Pfeiffer, B. Luderitz Effects of chronic amiodarone therapy on defibrillation threshold Am J Cardiol 70 1992 1023 1027
39. P Dorian, D. Newman Effect of sotalol on ventricular fibrillation and defibrillation in humans Am J Cardiol 72 1993 72A 79A
40. WG Stevenson, DJ Wilber, A Natale et al. Multicenter Thermocool VT Ablation Trial Investigators. Irrigated radiofrequency catheter ablation guided by electroanatomic mapping for recurrent ventricular tachycardia after myocardial infarction: the multicenter thermocool ventricular tachycardia ablation trial Circulation 118 2008 2773 2782
41. D Katritsis, M Hossein-Nia, A Anastasakis et al. Use of troponin-T concentration and kinase isoforms for quantitation of myocardial injury induced by radiofrequency catheter ablation Eur Heart J 18 1997 1007 1013
42. L Chen, T Wei, C Zeng, Q Chen, Z Shi, L. Wang Effect of radiofrequency catheter ablation on plasma B-type natriuretic peptide Pacing Clin Electrophysiol 28 2005 200 204
43. MERIT HF Study Group. Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF). Lancet 1999;353:2001-2007.
44. CIBIS II Investigators and Committees. The cardiac insufficiency bisoprolol study II (CIBIS II): a randomized trial. Lancet 1999;353:9-13.
45. M Packer, AJ Coats, MB Fowler et al. Carvedilol Prospective Randomized Cumulative Survival Study Group. Effect of carvedilol on survival in severe chronic heart failure N Engl J Med 344 2001 1651 1658
46. EB Schron, DV Exner, Q Yao et al. the AVID Investigators. Quality of life in the antiarrhythmics versus implantable defibrillators trial: impact of therapy and influence of adverse symptoms and defibrillator shocks. Circulation 105 2002 589 594
47. M Ahmad, L Bloomstein, M Roelke, AD Bernstein, V. Parsonnet Patients' attitudes toward implanted defibrillator shocks Pacing Clin Electrophysiol 23 2000 934 938
48. C Herrmann, F von zur Mühen, A Schaumann et al. Standardized assessment of psychological well-being and quality-of-life in patients with implanted defibrillators Pacing Clin Electrophysiol 20 1997 95 103
49. JP Bourke, D Turkington, G Thomas, JM McComb, M. Tynan Florid psychopathology in patients receiving shocks from implanted cardioverter- defibrillators Heart 78 1997 581 583